Chris Bond

Chris Bond

Company: Notch Therapeutics

Job title: Senior Vice President Preclinical & Translational Sciences


Engineered iPS Derived T-Cells for Solid & Hematological Tumours 12:30 pm

Engineered iPS derived cell therapies can be designed to overcome multiple mechanisms of treatment failure and relapse PSC derived therapies provide a homogenous and uniform source of off-the-shelf cell therapy productsRead more

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.